HEADER TRANSPORT PROTEIN 15-APR-20 6WK5 TITLE CRYSTAL STRUCTURE OF GDX-CLO FROM SMALL MULTIDRUG RESISTANCE FAMILY OF TITLE 2 TRANSPORTERS COMPND MOL_ID: 1; COMPND 2 MOLECULE: MULTIDRUG RESISTANCE PROTEIN, SMR FAMILY; COMPND 3 CHAIN: B, A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: L10 MONOBODY; COMPND 7 CHAIN: C, D; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CLOSTRIDIALES BACTERIUM ORAL TAXON 876 STR. SOURCE 3 F0540; SOURCE 4 ORGANISM_TAXID: 1321778; SOURCE 5 GENE: HMPREF1982_00479; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-21C; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS SMALL MULTIDRUG RESISTANCE, GUANIDINIUM TRANSPORTER, EMRE HOMOLOGUE, KEYWDS 2 DUAL TOPOLOGY PROTEIN, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.A.KERMANI,R.B.STOCKBRIDGE REVDAT 2 09-DEC-20 6WK5 1 JRNL REVDAT 1 28-OCT-20 6WK5 0 JRNL AUTH A.A.KERMANI,C.B.MACDONALD,O.E.BURATA,B.BEN KOFF,A.KOIDE, JRNL AUTH 2 E.DENBAUM,S.KOIDE,R.B.STOCKBRIDGE JRNL TITL THE STRUCTURAL BASIS OF PROMISCUITY IN SMALL MULTIDRUG JRNL TITL 2 RESISTANCE TRANSPORTERS. JRNL REF NAT COMMUN V. 11 6064 2020 JRNL REFN ESSN 2041-1723 JRNL PMID 33247110 JRNL DOI 10.1038/S41467-020-19820-8 REMARK 2 REMARK 2 RESOLUTION. 3.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.23 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 10071 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.253 REMARK 3 R VALUE (WORKING SET) : 0.252 REMARK 3 FREE R VALUE : 0.286 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 512 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.2300 - 5.5500 1.00 2457 133 0.2550 0.2827 REMARK 3 2 5.5500 - 4.4100 1.00 2377 122 0.2370 0.2555 REMARK 3 3 4.4100 - 3.8500 1.00 2361 126 0.2531 0.2924 REMARK 3 4 3.8500 - 3.5000 1.00 2364 131 0.2700 0.3734 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.540 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.780 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 101.9 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6WK5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-APR-20. REMARK 100 THE DEPOSITION ID IS D_1000248480. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-OCT-19 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9786 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10080 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.500 REMARK 200 RESOLUTION RANGE LOW (A) : 54.140 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.500 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.83 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.14800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 71.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M LINO3, 0.1 M N-(2 REMARK 280 -ACETAMIDO)IMINODIACETIC ACID (ADA) PH 6.8, AND 35% PEG 600, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 70.90000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 25.54650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 70.90000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 25.54650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 105 REMARK 465 SER A 105 REMARK 465 VAL C 2 REMARK 465 SER C 3 REMARK 465 VAL D 2 REMARK 465 SER D 3 REMARK 465 SER D 4 REMARK 465 VAL D 5 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 40 CA - CB - CG ANGL. DEV. = 15.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 24 -125.95 -87.20 REMARK 500 ILE A 30 -62.23 100.34 REMARK 500 LEU A 82 68.46 -119.29 REMARK 500 THR A 103 -73.80 -79.82 REMARK 500 PRO C 47 80.89 -64.41 REMARK 500 TRP D 28 -80.42 52.56 REMARK 500 ASN D 45 -103.44 55.80 REMARK 500 SER D 46 -164.43 58.07 REMARK 500 ASP D 81 38.65 -79.83 REMARK 500 TYR D 82 -100.00 -133.71 REMARK 500 SER D 84 156.52 68.29 REMARK 500 TYR D 90 137.38 -170.37 REMARK 500 REMARK 500 REMARK: NULL DBREF 6WK5 B 1 105 UNP U2EQ00 U2EQ00_9FIRM 1 105 DBREF 6WK5 A 1 105 UNP U2EQ00 U2EQ00_9FIRM 1 105 DBREF 6WK5 C 2 92 PDB 6WK5 6WK5 2 92 DBREF 6WK5 D 2 92 PDB 6WK5 6WK5 2 92 SEQRES 1 B 105 MSE ALA TRP LEU ILE LEU ILE ILE ALA GLY ILE PHE GLU SEQRES 2 B 105 VAL VAL TRP ALA ILE ALA LEU LYS TYR SER ASN GLY PHE SEQRES 3 B 105 THR ARG LEU ILE PRO SER MSE ILE THR LEU ILE GLY MSE SEQRES 4 B 105 LEU ILE SER PHE TYR LEU LEU SER GLN ALA THR LYS THR SEQRES 5 B 105 LEU PRO ILE GLY THR ALA TYR ALA ILE TRP THR GLY ILE SEQRES 6 B 105 GLY ALA LEU GLY ALA VAL ILE CYS GLY ILE ILE PHE PHE SEQRES 7 B 105 LYS GLU PRO LEU THR ALA LEU ARG ILE VAL PHE MSE ILE SEQRES 8 B 105 LEU LEU LEU THR GLY ILE ILE GLY LEU LYS ALA THR SER SEQRES 9 B 105 SER SEQRES 1 A 105 MSE ALA TRP LEU ILE LEU ILE ILE ALA GLY ILE PHE GLU SEQRES 2 A 105 VAL VAL TRP ALA ILE ALA LEU LYS TYR SER ASN GLY PHE SEQRES 3 A 105 THR ARG LEU ILE PRO SER MSE ILE THR LEU ILE GLY MSE SEQRES 4 A 105 LEU ILE SER PHE TYR LEU LEU SER GLN ALA THR LYS THR SEQRES 5 A 105 LEU PRO ILE GLY THR ALA TYR ALA ILE TRP THR GLY ILE SEQRES 6 A 105 GLY ALA LEU GLY ALA VAL ILE CYS GLY ILE ILE PHE PHE SEQRES 7 A 105 LYS GLU PRO LEU THR ALA LEU ARG ILE VAL PHE MSE ILE SEQRES 8 A 105 LEU LEU LEU THR GLY ILE ILE GLY LEU LYS ALA THR SER SEQRES 9 A 105 SER SEQRES 1 C 91 VAL SER SER VAL PRO THR LYS LEU GLU VAL VAL ALA ALA SEQRES 2 C 91 THR PRO THR SER LEU LEU ILE SER TRP ASP ALA GLY HIS SEQRES 3 C 91 TRP TRP GLU TRP VAL THR TYR TYR ARG ILE THR TYR GLY SEQRES 4 C 91 GLU THR GLY GLY ASN SER PRO VAL GLN GLU PHE THR VAL SEQRES 5 C 91 PRO GLY TYR SER SER THR ALA THR ILE SER GLY LEU LYS SEQRES 6 C 91 PRO GLY VAL ASP TYR THR ILE THR VAL TYR ALA PRO THR SEQRES 7 C 91 SER ASP TYR GLY SER PRO ILE SER ILE ASN TYR ARG THR SEQRES 1 D 91 VAL SER SER VAL PRO THR LYS LEU GLU VAL VAL ALA ALA SEQRES 2 D 91 THR PRO THR SER LEU LEU ILE SER TRP ASP ALA GLY HIS SEQRES 3 D 91 TRP TRP GLU TRP VAL THR TYR TYR ARG ILE THR TYR GLY SEQRES 4 D 91 GLU THR GLY GLY ASN SER PRO VAL GLN GLU PHE THR VAL SEQRES 5 D 91 PRO GLY TYR SER SER THR ALA THR ILE SER GLY LEU LYS SEQRES 6 D 91 PRO GLY VAL ASP TYR THR ILE THR VAL TYR ALA PRO THR SEQRES 7 D 91 SER ASP TYR GLY SER PRO ILE SER ILE ASN TYR ARG THR MODRES 6WK5 MSE B 1 MET MODIFIED RESIDUE MODRES 6WK5 MSE B 33 MET MODIFIED RESIDUE MODRES 6WK5 MSE B 39 MET MODIFIED RESIDUE MODRES 6WK5 MSE B 90 MET MODIFIED RESIDUE MODRES 6WK5 MSE A 1 MET MODIFIED RESIDUE MODRES 6WK5 MSE A 33 MET MODIFIED RESIDUE MODRES 6WK5 MSE A 39 MET MODIFIED RESIDUE MODRES 6WK5 MSE A 90 MET MODIFIED RESIDUE HET MSE B 1 8 HET MSE B 33 8 HET MSE B 39 8 HET MSE B 90 8 HET MSE A 1 8 HET MSE A 33 8 HET MSE A 39 8 HET MSE A 90 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 8(C5 H11 N O2 SE) HELIX 1 AA1 MSE B 1 SER B 23 1 23 HELIX 2 AA2 ARG B 28 LEU B 53 1 26 HELIX 3 AA3 PRO B 54 LYS B 79 1 26 HELIX 4 AA4 THR B 83 THR B 103 1 21 HELIX 5 AA5 ALA A 2 SER A 23 1 22 HELIX 6 AA6 ILE A 30 LEU A 53 1 24 HELIX 7 AA7 PRO A 54 PHE A 78 1 25 HELIX 8 AA8 THR A 83 SER A 104 1 22 SHEET 1 AA1 3 THR C 7 ALA C 14 0 SHEET 2 AA1 3 LEU C 19 ASP C 24 -1 O ASP C 24 N THR C 7 SHEET 3 AA1 3 THR C 59 ILE C 62 -1 O ALA C 60 N ILE C 21 SHEET 1 AA2 4 GLN C 49 PRO C 54 0 SHEET 2 AA2 4 TYR C 34 GLU C 41 -1 N ILE C 37 O PHE C 51 SHEET 3 AA2 4 ASP C 70 TYR C 76 -1 O THR C 72 N GLY C 40 SHEET 4 AA2 4 ILE C 86 ARG C 91 -1 O ILE C 86 N VAL C 75 SHEET 1 AA3 3 THR D 7 THR D 15 0 SHEET 2 AA3 3 SER D 18 ASP D 24 -1 O ASP D 24 N THR D 7 SHEET 3 AA3 3 THR D 59 SER D 63 -1 O ALA D 60 N ILE D 21 SHEET 1 AA4 4 GLN D 49 PRO D 54 0 SHEET 2 AA4 4 TYR D 34 GLU D 41 -1 N TYR D 39 O GLN D 49 SHEET 3 AA4 4 ASP D 70 TYR D 76 -1 O THR D 74 N THR D 38 SHEET 4 AA4 4 ILE D 86 ARG D 91 -1 O TYR D 90 N TYR D 71 LINK C MSE B 1 N ALA B 2 1555 1555 1.34 LINK C SER B 32 N MSE B 33 1555 1555 1.33 LINK C MSE B 33 N ILE B 34 1555 1555 1.33 LINK C GLY B 38 N MSE B 39 1555 1555 1.33 LINK C MSE B 39 N LEU B 40 1555 1555 1.34 LINK C PHE B 89 N MSE B 90 1555 1555 1.33 LINK C MSE B 90 N ILE B 91 1555 1555 1.33 LINK C MSE A 1 N ALA A 2 1555 1555 1.34 LINK C SER A 32 N MSE A 33 1555 1555 1.33 LINK C MSE A 33 N ILE A 34 1555 1555 1.34 LINK C GLY A 38 N MSE A 39 1555 1555 1.33 LINK C MSE A 39 N LEU A 40 1555 1555 1.34 LINK C PHE A 89 N MSE A 90 1555 1555 1.33 LINK C MSE A 90 N ILE A 91 1555 1555 1.33 CISPEP 1 VAL C 5 PRO C 6 0 -5.05 CRYST1 141.800 51.093 108.433 90.00 93.08 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007052 0.000000 0.000379 0.00000 SCALE2 0.000000 0.019572 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009236 0.00000 HETATM 1 N MSE B 1 -9.403 -43.016 -38.985 1.00 95.12 N HETATM 2 CA MSE B 1 -10.405 -42.394 -38.123 1.00103.30 C HETATM 3 C MSE B 1 -9.969 -41.022 -37.633 1.00101.13 C HETATM 4 O MSE B 1 -10.702 -40.045 -37.796 1.00 99.78 O HETATM 5 CB MSE B 1 -10.709 -43.294 -36.919 1.00108.10 C HETATM 6 CG MSE B 1 -12.116 -43.871 -36.941 1.00123.10 C HETATM 7 SE MSE B 1 -13.486 -42.500 -37.183 1.00169.55 SE HETATM 8 CE MSE B 1 -14.322 -42.596 -35.423 1.00122.48 C